Provided by Tiger Trade Technology Pte. Ltd.

Keros Therapeutics, Inc.

17.57
+0.33001.91%
Post-market: 17.570.00000.00%17:08 EST
Volume:305.49K
Turnover:5.37M
Market Cap:535.29M
PE:11.16
High:17.90
Open:17.45
Low:17.35
Close:17.24
52wk High:22.55
52wk Low:9.12
Shares:30.47M
Float Shares:22.55M
Volume Ratio:1.13
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.57
EPS(LYR):-5.0044
ROE:10.43%
ROA:4.40%
PB:0.76
PE(LYR):-3.51

Loading ...

Keros Therapeutics Highlights Rinvatercept Strategy in Updated Presentation

TIPRANKS
·
Jan 10

Keros Therapeutics (KROS): Valuation Check After Sharp Share Price Rebound and Ongoing Revenue Contraction Forecasts

Simply Wall St.
·
Dec 08, 2025

BRIEF-Keros Therapeutics Announces Final Results Of Tender Offer

Reuters
·
Nov 21, 2025

Keros to Repurchase 11 Million Shares in Oversubscribed Tender Offer

MT Newswires Live
·
Nov 19, 2025

Keros Therapeutics Inc - Announces Tender Offer to Repurchase Common Shares for $194.4 Mln

THOMSON REUTERS
·
Nov 19, 2025

Keros Therapeutics Inc. : Oppenheimer Raises Target Price to $27 From $23

THOMSON REUTERS
·
Nov 12, 2025

Biopharma company Keros' Q3 net loss narrows on Takeda license revenue

Reuters
·
Nov 06, 2025

Keros Therapeutics reports third quarter net loss of $7.3 million

Reuters
·
Nov 06, 2025

Keros Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview

Reuters
·
Nov 01, 2025

Keros Initiates Share Repurchase Program of Up to $194.4 Million

Deep News
·
Oct 20, 2025

Keros Therapeutics to repurchase $194.4M of shares

TIPRANKS
·
Oct 20, 2025

Keros Therapeutics Inc - Expects to Fund Tender Offer From Its Existing Cash and Cash Equivalents

THOMSON REUTERS
·
Oct 20, 2025

Pontifax Management 4 G.P. (2015) Ltd. Reports Disposal of Keros Therapeutics Inc. Common Shares

Reuters
·
Oct 18, 2025

Major Shareholder Sells Millions in Keros Therapeutics Stock!

TIPRANKS
·
Oct 16, 2025

ADAR1 Capital Management, LLC Reports Disposal of Common Shares of Keros Therapeutics Inc

Reuters
·
Oct 16, 2025

Keros Therapeutics Inc - Aggregate Purchase Price for Repurchase Is $181 Mln

THOMSON REUTERS
·
Oct 15, 2025

Keros Therapeutics Inc - to Distribute 25% of Takeda Proceeds to Stockholders

THOMSON REUTERS
·
Oct 15, 2025

Keros Therapeutics Inc - Intends to Commence Tender Offer for $194 Mln in Shares

THOMSON REUTERS
·
Oct 15, 2025

Press Release: Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital

Dow Jones
·
Oct 15, 2025

Keros Therapeutics Unveils Promising Phase 1 Trial Results for KER-065 at 2025 ASBMR Meeting, Highlighting Potential in Duchenne Muscular Dystrophy and Bone Disorders

Reuters
·
Sep 08, 2025